Solid Biosciences Statistics
NASDAQ: SLDBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
6.82-0.03 (-0.44%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Solid Biosciences by the numbers
Solid Biosciences has a market capitalization of $731.3 million based on 107.23M shares outstanding. With trailing EPS of $-1.89, Solid Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.3% below its 50-day average and 10.5% below its 200-day average.
Average daily trading volume is 1.10M shares, or about $7.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SLDB valuation vs. peer median
| Metric | SLDB | Peer median | Difference |
|---|---|---|---|
| Market cap | $731.28M | $688.10M | +6% |
| Avg. volume | 1.10M | 833.61K | +31% |
Peer median across 8 companies: FDMT, AURA, PROK, PRME, SANA, SLBT, DBVT, ODTX.
Valuation
- Market cap
- $731.28M
- EPS (TTM)
- $-1.89
- Shares outstanding
- 107.23M
Price and trading
- Previous close
- 6.85
- Open
- 6.75
- Day range
- 6.64 – 6.88
- 52-week range
- 3.79 – 11.45
- 52-week change
- +8.08%
- Beta
- —
- Volume
- 1.31M
- Average volume
- 1.10M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 731.28M
- Forward Pe
- -4.00
- Eps
- -1.89
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 11.45
- Week52 Low
- 3.79
- Avg Volume
- 1.10M
- Shares Outstanding
- 107.23M
- Ma50
- 8.67
- Ma200
- 7.62
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -40.44%
- Pct From52w Low
- 79.95%